Measurement of circulating troponin Ic enhances the prognostic value of C-reactive protein in haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 19, Issue 9, 2004, Pages 2313-2318

  Boulier, Alexandre ^a   Jaussent, Isabelle ^b   Terrier, Nathalie ^a   Maurice, François ^c   Rivory, Jean Pierre ^c   Chalabi, Lotfi ^e   Boularan, Anne Marie ^a   Delcourt, Cécile ^b   Dupuy, Anne Marie ^a   Canaud, Bernard ^d,e,f   Cristol, Jean Paul ^a  

^a Biochemistry Laboratory   (France)

^b INSERM   (France)

^c Centre Hemodialyse Languedoc Mediterranee   (France)

^d MONTPELLIER UNIVERSITY HOSPITAL   (France)

^e AIDER   (France)

^f Renal Research and Training Institute   (France)

Author keywords

Cardiovascular disease; Haemodialysis; Mortality; Troponin

Indexed keywords

C REACTIVE PROTEIN; TROPONIN I;

ADULT; AGE; AGED; ARTICLE; CAUSE OF DEATH; CIRCULATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; GENDER; HEART DEATH; HEMODIALYSIS PATIENT; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MORTALITY; NONBIOLOGICAL MODEL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS; TROPONIN I;

EID: 4544261268     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh365     Document Type: Article

References (20)

1. Wu AHB, Apple FS, Gilbler WB, Jesse RL, Warshaw MM, Valdes R. National Academy of Clinical Biochemestry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999; 45: 1104-1121
2. Apple FS, Wu AHB, Jaffe AS. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J. 2002; 144: 981-986
3. Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined - a consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Cardiol 2000; 36: 959-969
4. Khan IA, Wattanasuwan N, Mehta NJ et al. Prognostic value of serum cardiac troponin I in ambulatory patients with chronic renal failure undergoing long-term hemodialysis: a two-year outcome analysis. J Am Coll Cardiol 2001; 38: 991-998
5. Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 2002; 106: 2941-2945
6. Dierkes J, Domrose U, Westphal S, Ambrosch A, Bosselmann HP, Neumann KH, Luley C. Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation 2000; 102: 1964-1969
7. Stoffel MP, Pollok M, Baldamus CA. Troponin I is a better prognostic parameter of cardiovascular events in asymptomatic patients on haemodialysis than troponin T. Nephrol Dial Transplant 2000; 15: 1259-1260.
8. Chen P, Tanasijevic M. Use of serum cardiac troponin-I levels in dialysis patients. Semin Dial 2000; 13: 58-59
9. London GM. Cardiovascular disease in chronic renal failure: pathophysiologic aspects. Semin Dial 2003; 16: 85-94
10. Stenvinkel P, Heimbürger O, Paultre F et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55: 1899-1911
11. Owen WF, Lowrie EG. C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int 1998; 54: 627-636
12. Wanner C, Zimmermann J, Schwelder S, Metzger T. Inflammation and cardiovascular risk in dialysis patients. Kidney Int 2002; 61 [Suppl 80]: S99-S102.
13. Uettwiller-Geiger D, Wu AH, Apple FS et al. Multicenter evaluation of an automated assay for troponin I. Clin Chem 2002; 48: 869-876
14. Sheehan P, Blennerhassett J, Vasikaran SD. Decision limit for troponin I and assay performance. Ann Clin Biochem 2002; 39: 231-236
15. Nakamura S, Uzu T, Inenaga T, Kimura G. Prediction of coronary artery disease and cardiac events using electrocardiographic changes during hemodialysis. Am J Kidney Dis 2000; 36: 592-599
16. Mallamaci F, Zoccali C, Parlongo S et al. Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2002; 40: 68-75
17. Brancaccio D, Tetta C, Gallieni M, Panichi V. Inflammation, CRP, calcium overload and a high calcium-phosphate product: a 'liaison dangereuse'. Nephrol Dial Transplant 2002; 17: 201-203.
18. Park CW, Shin YS, Kim CM et al. Increased C-reactive protein following hemodialysis predicts cardiac hypertrophy in chronic hemodialysis patients. Am J Kidney Dis 2002; 40: 1230-1239
19. Chauveau P, Level C, Lasseur C et al. C-reactive protein and procalcitonin as markers of mortality in hemodialysis patients: a 2-year prospective study. J Ren Nutr 2003; 13: 137-143
20. Lowbeer C, Stenvinkel P, Pecoits-Filho R et al. Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality. J Intern Med 2003; 253: 153-160